Trial intelligence / Profile preview

Montelukast for postoperative breast cancer-related lymphedema

ChiCTR2000030676Phase 4Recruiting

Sponsor
The Fifth Affiliated Hospital of Sun Yat-sen University
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of montelukast in lymphedema (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Upper limb circumference, CD4+ T cell and 2 more. Started Dec 2019; status: recruiting.

02

Drugs

montelukast
03

Conditions

lymphedema

Beyond the preview

Go deeper on ChiCTR2000030676.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030676.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call